Infographic

A decision-led pathway from opportunity brief and feasibility to manufacturer qualification, packaging, regulatory planning and launch.

2 min

A private-label launch combines a commercial brief with product classification, manufacturer due diligence and operational controls. Establish the legal and quality responsibilities before committing to artwork or inventory.

01

Write the concept brief

Define intended use, claims, user group, pack size, target markets and channel. Estimate landed cost using realistic order quantities, testing, artwork, freight, storage, rejects and returns.

  • Decision: Proceed only when the proposition and cost basis are documented.
02

Confirm the regulatory pathway

Classify the product and identify the responsible party, manufacturer and applicable site and product permissions. For pharmaceutical contract manufacturing in Pakistan, check the DRAP Form 5F guidance and applicable Rule 20-A provisions. Other product categories follow their own routes.

  • Decision: Confirm classification, claims and authorization responsibilities before locking artwork.
03

Qualify the manufacturing partner

Check the exact manufacturing site, authorized scope, subcontracting, test capability, audit evidence and capacity. Evaluate samples against agreed specifications and record the disposition of gaps.

  • Decision: Approve the specific site and scope against documented acceptance criteria.
04

Set specifications and responsibilities

Control the formula or bill of materials, packaging drawings, methods and claims. Assign release, change notification, complaint investigation, record access and recall responsibilities in the quality agreement.

  • Decision: Approve the specifications, artwork revision and quality agreement.
05

Release and monitor the launch

Verify first-lot records, acceptance results, traceability and applicable permissions. Assign owners for complaints, returns, stock rotation and post-launch changes before distribution.

  • Decision: Release the lot only when applicable regulatory and quality gates are satisfied.